Client 1st Advisory Group
ABBV icon

Client 1st Advisory Group’s AbbVie ABBV Stock Holding History

Client 1st Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$329K Sell
1,258
-6
-0.5% -$1.54K 0.08% 102
2026
Q2 		$318K Sell
1,264
-6
-0.5% -$1.29K 0.08% 107
2026
Q1 		$276K Buy
1,270
+5
+0.4% +$1.11K 0.08% 109
2025
Q4 		$289K Buy
1,265
+289
+30% +$65.8K 0.09% 114
2025
Q3 		$226K Buy
+976
New +$199K 0.07% 121
2025
Q2 		– Sell
-964
Closed -$202K – 133
2025
Q1 		$202K Buy
+964
New +$187K 0.08% 128

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Client 1st Advisory Group's ABBV Position: Q3 2026 in Review

Client 1st Advisory Group reduced its AbbVie (ABBV) stake by 0.47% in Q3 2026, selling an estimated $1.54K and leaving 1,258 shares worth $329K. The position accounts for 0.08% of the portfolio, ranked #102.

Client 1st Advisory Group first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 1,209 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Client 1st Advisory Group held 1,258 shares of AbbVie worth $329K as of Q3 2026.
  • Client 1st Advisory Group sold 6 AbbVie shares in Q3 2026, an estimated $1.54K.
  • AbbVie made up 0.08% of Client 1st Advisory Group's portfolio in Q3 2026, its #102 holding.
  • Client 1st Advisory Group first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 1,209 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Client 1st Advisory Group's 13F filing for Q3 2026, filed 19 Oct 2026.